James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 10,000 shares at $1.56 ($16K) on 2019-06-06, disclosed to the SEC on 2019-06-07.
Open-market purchase of $16k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.52 | 1,000 | $2K | 9.7% |
| 2 | $1.53 | 1,100 | $2K | 10.8% |
| 3 | $1.53 | 400 | $612 | 3.9% |
| 4 | $1.54 | 799 | $1K | 7.9% |
| 5 | $1.55 | 800 | $1K | 7.9% |
| 6 | $1.56 | 600 |
| $936 |
| 6.0% |
| 7 | $1.58 | 100 | $158 | 1.0% |
| 8 | $1.59 | 5,201 | $8K | 52.8% |
| Total | $1.56 avg | 10,000 | $16K | 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |